Nepafenac
Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) used in ophthalmic preparations to reduce eye pain and inflammation, particularly following cataract surgery. It acts as a prodrug that is converted within ocular tissues to amfenac, which inhibits cyclooxygenase enzymes and reduces prostaglandin production responsible for inflammation and pain. Nepafenac is available as an ophthalmic suspension, commonly in 0.1% and 0.3% strengths, depending on the market and approved indication. Common side effects include temporary eye discomfort, redness, irritation, blurred vision, and a foreign-body sensation. Prolonged use may delay corneal healing and increase the risk of corneal complications, especially in patients with pre-existing ocular surface disease or diabetes. Nepafenac should be used according to an ophthalmologist’s instructions, with appropriate monitoring of corneal health and recovery after surgery.
Nepafenac was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Nepafenac, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Nepafenac from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Nepafenac, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
